Skip to main content
SpringerLink
Log in

Medication Optimisation in Older People

  • Chapter
  • First Online:
Pharmaceutical Formulations for Older Patients

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 51))

  • 182 Accesses

Abstract

The population of the UK and many countries worldwide is ageing. Older people tend to suffer from more diseases and therefore take more medication. This is in addition to other factors, such as physical and mental frailty, which can make medication optimisation more challenging in older people.

This chapter introduces some of the key challenges associated with optimising medications for older people. It explores key social and clinical areas in older people and how this relates to medication optimisation including areas such as evidence-based prescribing, frailty, dementia, polypharmacy, deprescribing and swallowing difficulties. Ultimately, it aims to encourage person-centred care when optimising medications in the older person.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Age UK. Later life in the United Kingdom 2019 – Factsheet; 2019. p. 27.

    Google Scholar 

  2. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005;2:223–8.

    Article  Google Scholar 

  3. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43. https://doi.org/10.1016/S0140-6736(12)60240-2.

    Article  PubMed  Google Scholar 

  4. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):1–10. https://doi.org/10.1186/s12877-017-0621-2.

    Article  Google Scholar 

  5. National Institute for Health and Care Excellence (NICE). Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NICE guideline NG5. Available at: https://www.nice.org.uk/guidance/ng5 (2015). Accessed 19 July 2021.

  6. Gao L, Maidment I, Matthews FE, Robinson L, Brayne C, Medical Research Council Cognitive Function and Ageing Study. Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II. Age Ageing. 2018;47(2):220–5. https://doi.org/10.1093/ageing/afx158.

    Article  PubMed  Google Scholar 

  7. Maidment I, Huckerby C, Shukla D. Medication management in older people – a hidden burden. Prescriber. 2020;31(11–12):30–3. https://doi.org/10.1002/psb.1881.

    Article  Google Scholar 

  8. Audit Commission. A spoonful of sugar: medicines management in NHS hospitals. London; 2001.

    Google Scholar 

  9. National Institute for Health and Clinical Excellence (NICE). Medicines Adherence: Involving patiens in decisions about prescribed medicines and supporting adherence. Clinical guideline CG76. Available at: https://www.nice.org.uk/guidance/cg76 (2009). Accessed 19 July 2021.

  10. Balint E. The possibilities of patient-centered medicine. J R Coll Gen Pract. 1969;17(82)

    Google Scholar 

  11. Ekman I, Swedberg K, Taft C, Lindseth A, Norberg A, Brink E, Carlsson J, Dahlin-Ivanoff S, Johansson IL, Kjellgren K, Lidén E. Person-centered care – ready for prime time. Eur J Cardiovasc Nurs. 2011;10(4):248–51. https://doi.org/10.1016/j.ejcnurse.2011.06.008.

    Article  PubMed  Google Scholar 

  12. Santana MJ, Manalili K, Jolley RJ, Zelinsky S, Quan H, Lu M. How to practice person-centred care: a conceptual framework. Health Expect. 2018;21(2):429–40. https://doi.org/10.1111/hex.12640.

    Article  PubMed  Google Scholar 

  13. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol Ser A Biol Sci Med Sci. 2007:722–7. https://doi.org/10.1093/gerona/62.7.722.

  14. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5) https://doi.org/10.1503/cmaj.050051.

  15. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. https://doi.org/10.1016/S0140-6736(12)62167-9.

    Article  PubMed  Google Scholar 

  16. Dent E, Kowal P, Hoogendijk EO. Frailty measurement in research and clinical practice: a review. Eur J Intern Med. 2016; https://doi.org/10.1016/j.ejim.2016.03.007.

  17. NHS England. NHS England identifying frailty. [online] NHS England. Available at: https://www.england.nhs.uk/ourwork/clinical-policy/older-people/frailty/frailty-risk-identification/ (2021). Accessed 23 Oct 2021.

  18. Hilmer SN, Gnjidic D. Prescribing for frail older people. Aust Prescr. 2017;40(5):174–8. https://doi.org/10.18773/austprescr.2017.055.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Peklar J, O’Halloran AM, Maidment ID, Henman MC, Kenny RA, Kos M. Sedative load and frailty among community-dwelling population aged ≥65 years. J Am Med Dir Assoc. 2015;16(4):282–9. https://doi.org/10.1016/j.jamda.2014.10.010.

  20. Thanapluetiwong S, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. Vitamin D supplement on prevention of fall and fracture: a meta-analysis of randomized controlled trials. Medicine. 2020;99(34):e21506. https://doi.org/10.1097/MD.0000000000021506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. British Geriatrics Society. Fit for Frailty- Consensus best practice guidance for the care of older people living in community and outpatient settings’ [online] Available at: https://www.bgs.org.uk/sites/default/files/content/resources/files/2018-05-23/fff_full.pdf (2014). Accessed 4 Sept 2021.

  22. NHS England. Network contract directed enhanced service: contract specification 2020/21 – PCN requirements and entitlements. [online] Available at: https://www.england.nhs.uk/publication/des-contract-specification-2020-21-pcn-entitlements-and-requirements/ (2020). Accessed: 12 Sept 2021.

  23. British Geriatrics Society. End of life care in frailty: medicines management [online] Available at: https://www.bgs.org.uk/resources/end-of-life-care-in-frailty-medicines-management (2020). Accessed: 4 Sept 2021.

  24. Maidment I, Lawson S, Wong G, Booth A, Watson A, Zaman H, Mullan J, McKeown J, Bailey S. Towards an understanding of the burdens of medication management affecting older people: the MEMORABLE realist synthesis. BMC Geriatr. 2020;20(1):183. https://doi.org/10.1186/s12877-020-01568-x.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Maidment ID, Lawson S, Wong G, Booth A, Watson A, McKeown J, Zaman H, Mullan J, Bailey S. Medication management in older people: realist approaches based on literature and evaluation (MEMORABLE): a realist synthesis. NIHR J Library. 2020;8(26)

    Google Scholar 

  26. Nakham, A., Myint, P.K., Bond, C.M., Newlands, R., Loke, Y.K. and Cruickshank, M. (2020) ‘Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review’, J Am Med Dir Assoc 172–180.e5. https://doi.org/10.1016/j.jamda.2019.06.001.

  27. Richardson K, Bennett K, Maidment ID, Fox C, Smithard D, Kenny RA. Use of medications with anticholinergic activity and self-reported injurious falls in older community-dwelling adults. J Am Geriatr Soc. 2015;63(8):1561–9. https://doi.org/10.1111/jgs.13543.

    Article  PubMed  Google Scholar 

  28. Richardson K, Loke YK, Fox C, Maidment I, Howard R, Steel N, Arthur A, Boyd PJ, Aldus C, Ballard C, Savva GM. Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study. BMC Med. 2020;18(1):1–15. https://doi.org/10.1186/s12916-020-01821-5.

    Article  CAS  Google Scholar 

  29. Coupland C, Hill T, Morriss R, Moore M, Arthur A, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database. BMC Med. 2018;16(1):1–24. https://doi.org/10.1186/s12916-018-1022-x.

    Article  CAS  Google Scholar 

  30. Ng BJ, Le Couteur DG, Hilmer SN. Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients. Drugs Aging. 2018;35(6):493–521. https://doi.org/10.1007/s40266-018-0544-4.

    Article  CAS  PubMed  Google Scholar 

  31. Juraschek SP, Simpson LM, Davis BR, Beach JL, Ishak A, Mukamal KJ. Effects of antihypertensive class on falls, syncope, and orthostatic hypotension in older adults: the ALLHAT trial. Hypertension. 2019;74(4):1033–40. https://doi.org/10.1161/HYPERTENSIONAHA.119.13445.

    Article  CAS  PubMed  Google Scholar 

  32. Maidment ID, Fox C, Boustani M. A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson’s disease dementia. Acta Psychiatr Scand. 2005;111(6):403–9. https://doi.org/10.1111/j.1600-0447.2005.00516.x.

    Article  CAS  PubMed  Google Scholar 

  33. Richardson K, Savva GM, Boyd PJ, Aldus C, Maidment I, Pakpahan E, Loke YK, Arthur A, Steel N, Ballard C, Howard R. Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies. Health Technol Assess. 2021;25(1) https://doi.org/10.3310/hta25010.

  34. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009:86–8. https://doi.org/10.1038/clpt.2008.224.

  35. Cruz-Jentoft AJ, Gutiérrez B. Upper age limits in studies submitted to a research ethics committee. Aging Clin Exp Res. 2010;22(2) https://doi.org/10.1007/BF03324793.

  36. Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013:319–26. https://doi.org/10.1007/s00228-012-1387-2.

  37. Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, Clarfield AM, Crome P, Hertogh C, Lesauskaite V, Prada GI. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–6. https://doi.org/10.1001/archinternmed.2011.31.

    Article  PubMed  Google Scholar 

  38. Bartlam B, Lally F, Crome P, Topinkova E, Clarfield AM, Cherubini A, Lesauskaite V, Hertogh C, Szczerbińska K, Prada GI, Farre A. The PREDICT study. Patients and carers views of older peoples participation in clinical trials. Age Ageing. 2011;40(Suppl 1):i73.

    Google Scholar 

  39. Crome P, Lally F, Cherubini A, Oristrell J, Beswick AD, Clarfield AM, Hertogh C, Lesauskaite V, Prada GI, Szczerbińska K, Topinkova E. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011;28(8):667–77. https://doi.org/10.2165/11591990-000000000-00000.

    Article  PubMed  Google Scholar 

  40. NHS Digital. National diabetes audit, 2020–21 quarterly report [online] Available at: https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/e4-data (2021). Accessed: 30 Oct 2021.

  41. Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021; https://doi.org/10.1038/s41574-021-00512-2.

  42. Strain WD, Down S, Brown P, Puttanna A, Sinclair A. Diabetes and frailty: an expert consensus statement on the management of older adults with type 2 diabetes. Diabetes Ther. 2021:1–21. https://doi.org/10.1007/s13300-021-01035-9.

  43. Duerden M, Payne R. Polypharmacy and medicines optimisation. The King’s Fund, pp. 1–68. Available at: http://www.kingsfund.org.uk/publications (2013). Accessed 14 Aug 2021.

  44. Wastesson JW, Morin L, Tan EC, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96. https://doi.org/10.1080/14740338.2018.1546841.

    Article  PubMed  Google Scholar 

  45. Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E, Molloy GJ. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11(9):e044987. https://doi.org/10.1136/bmjopen-2020-044987.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Paisansirikul A, Ketprayoon A, Ittiwattanakul W, Petchlorlian A. Prevalence and associated factors of drug-related problems among older people: a cross-sectional study at King Chulalongkorn Memorial Hospital in Bangkok. Drugs-Real World Outcomes. 2021;8(1):73–84. https://doi.org/10.1007/s40801-020-00219-2.

    Article  PubMed  Google Scholar 

  47. Department of Health and Social Care. Good for you, good for us, good for everybody: a plan to reduce overprescribing to make patient care better and safer, support the NHS, and reduce carbon emissions [online] Available at: https://www.gov.uk/government/publications/national-overprescribing-review-report (2021). Accessed: 23 Oct 2021.

  48. Grossi CM, Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Campbell N, Boustani M, Robinson L. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study. BMC Geriatr. 2019;19(1) https://doi.org/10.1186/s12877-019-1280-2.

  49. Pieper NT, Grossi CM, Chan WY, Loke YK, Savva GM, Haroulis C, Steel N, Fox C, Maidment ID, Arthur AJ, Myint PK. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis. Age Ageing. 2020;49(6) https://doi.org/10.1093/ageing/afaa090.

  50. Moriarty F, Savva GM, Grossi CM, Bennett K, Fox C, Maidment I, Loke YK, Steel N, Kenny RA, Richardson K. Cognitive decline associated with anticholinergics, benzodiazepines and Z-drugs: findings from the Irish longitudinal study on ageing (TILDA). Br J Clin Pharmacol. 2020; https://doi.org/10.1111/bcp.14687.

  51. Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20. https://doi.org/10.2217/1745509X.4.3.311.

    Article  CAS  Google Scholar 

  52. Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, Chica L. Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf. 2017;16(2):111–2.

    PubMed  Google Scholar 

  53. Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm. 2013;66(3):201.

    PubMed  PubMed Central  Google Scholar 

  54. Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre LM. Continuation or deprescribing of proton pump inhibitors: a consult patient decision aid. Can Pharm J. 2019;152(1) https://doi.org/10.1177/1715163518816719.

  55. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, Gnjidic D, Del Mar CB, Roughead EE, Page A, Jansen J. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–34. https://doi.org/10.1001/jamainternmed.2015.0324.

    Article  PubMed  Google Scholar 

  56. Smith H, Miller K, Barnett N, Oboh L, Jones E, Darcy C, McKee H, Agnew J, Crawford P. Person-centred care including deprescribing for older people. Pharmacy. 2019;7(3):101. https://doi.org/10.3390/pharmacy7030101.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Bokhof B, Junius-Walker U. Reducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studies. Drugs Aging. 2016; https://doi.org/10.1007/s40266-016-0354-5.

  58. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44(2):213–8. https://doi.org/10.1093/ageing/afu145.

    Article  PubMed  PubMed Central  Google Scholar 

  59. PrescQIPP. Ensuring appropriate polypharmacy: a practical guide to deprescribing. Bulletin 136 (2017, April):1–8. Available at: https://www.prescqipp.info/component/jdownloads/send/356-polypharmacy-practical-guide-to-deprescribing/3410-bulletin-176-p-d-practical-guide

  60. Lewis T. 10-minute consultation: using the NO TEARS tool for medication review. Br Med J. 2004:434. https://doi.org/10.1136/sbmj.0410362.

  61. NHS Scotland. Scottish government polypharmacy model of care group. Polypharmacy gidance, realistic prescribing. 3rd ed. NHS Scotland; 2018.

    Google Scholar 

  62. Farrell B, Pottie K, Thompson W, Boghossian T, Pizzola L, Rashid FJ, Rojas-Fernandez C, Walsh K, Welch V, Moayyedi P. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(5):354–64.

    Google Scholar 

  63. Farrell B, Black C, Thompson W, McCarthy L, Rojas-Fernandez C, Lochnan H, Shamji S, Upshur R, Bouchard M, Welch V. Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline. Can Fam Physician. 2017;63(11):832–43.

    Google Scholar 

  64. Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman-Wilms L, Rojas-Fernandez C, Sinha S, Thompson W, Welch V. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17–27. PMID: 29358245

    PubMed  PubMed Central  Google Scholar 

  65. Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Forbes F. Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine guidelines. In: Recommendations. Sydney: The University of Sydney; 2018.

    Google Scholar 

  66. Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339–51.

    PubMed  PubMed Central  Google Scholar 

  67. Wittenberg R Wittenberg R, Hu B, Barraza-Araiza L, Rehill A. Projections of older people with dementia and costs of dementia care in the United Kingdom, 2019–2040. CPEC working paper 5, (November). London: London School of Economics; 2019.

    Google Scholar 

  68. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council cognitive function and ageing study. J Am Geriatr Soc. 2011;59(8):1477–83. https://doi.org/10.1111/j.1532-5415.2011.03491.x.

    Article  PubMed  Google Scholar 

  69. Fox C, Livingston G, Maidment ID, Coulton S, Smithard DG, Boustani M, Katona C. The impact of anticholinergic burden in Alzheimer’s dementia-the laser-AD study. Age Ageing. 2011;40(6):730–5. https://doi.org/10.1093/ageing/afr102.

    Article  PubMed  Google Scholar 

  70. Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361:k1315. https://doi.org/10.1136/BMJ.K1315.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Maidment, I. Medication -related adverse events in older people with dementia causes and possible solutions. Doctoral dissertation, Aston University; 2013.

    Google Scholar 

  72. Maidment ID, Haw C, Stubbs J, Fox C, Katona C, Franklin BD. Medication errors in older people with mental health problems: a review. Int J Geriatr Psychiatry. 2008;23(6):564–73. https://doi.org/10.1002/gps.1943.

    Article  PubMed  Google Scholar 

  73. Aston L, Hilton A, Moutela T, Shaw R, Maidment I. Exploring the evidence base for how people with dementia and their informal carers manage their medication in the community: a mixed studies review. BMC Geriatr. 2017;17(1):242. https://doi.org/10.1186/s12877-017-0638-6.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Maidment I, et al. Developing a framework for a novel multi-disciplinary, multi-agency intervention(s), to improve medication management in community-dwelling older people on complex medication regimens (MEMORABLE) – a realist synthesis. Syst Rev. 2017;6(1) https://doi.org/10.1186/s13643-017-0528-1.

  75. Maidment ID, Aston L, Moutela T, Fox CG, Hilton A. A qualitative study exploring medication management in people with dementia living in the community and the potential role of the community pharmacist. Health Expect. 2017;20(5) https://doi.org/10.1111/hex.12534.

  76. Baijens LW, Clavé P, Cras P, Ekberg O, Forster A, Kolb GF, Leners JC, Masiero S, Mateos-Nozal J, Ortega O, Smithard DG. European society for swallowing disorders - European union geriatric medicine society white paper: oropharyngeal dysphagia as a geriatric syndrome. Clin Interv Aging. 2016; https://doi.org/10.2147/CIA.S107750.

  77. Hiltunen K, Saarela RK, Kautiainen H, Roitto HM, Pitkälä KH, Mäntylä P. Relationship between Fried’s frailty phenotype and oral frailty in long-term care residents. Age Ageing. 2021;afab177 https://doi.org/10.1093/ageing/afab177.

  78. Tanaka T, Takahashi K, Hirano H, Kikutani T, Watanabe Y, Ohara Y, Furuya H, Tetsuo T, Akishita M, Iijima K. Oral frailty as a risk factor for physical frailty and mortality in community-dwelling elderly. J Gerontol Ser A. 2018;73(12):1661–7. https://doi.org/10.1093/gerona/glx225.

    Article  Google Scholar 

  79. Ortega O, Cabre M, Clave P. Oropharyngeal dysphagia: aetiology and effects of ageing. J Gastroenterol Hepatol Res. 2014;3(5):1049–54.

    Google Scholar 

  80. Drumond N, Stegemann S. Better medicines for older patients: considerations between patient characteristics and solid oral dosage form designs to improve swallowing experience. Pharmaceutics. 2021;13(1):32. https://doi.org/10.3390/pharmaceutics13010032.

    Article  CAS  Google Scholar 

  81. Brennan K. Preparing and giving medicines for people with swallowing difficulties [online] Available at: https://www.sps.nhs.uk/articles/preparing-and-giving-medicines-for-people-with-swallowing-difficulties/ (2021). Accessed 23 Oct 2021.

  82. Aspen. Lanoxin PG Elixir SmPC [online] Available at: https://www.medicines.org.uk/emc/product/5463/smpc (2020). Accessed 24 Oct 2021.

  83. Ryu GS, Lee YJ. Analysis of liquid medication dose errors made by patients and caregivers using alternative measuring devices. J Manag Care Pharm. 2012;18(6):439–45. https://doi.org/10.18553/jmcp.2012.18.6.439.

    Article  PubMed  Google Scholar 

  84. Barnett N, Parmar P. Tailoring medication formulations for patients with dysphagia. Pharm J. 2016;297(7892):106–8. https://doi.org/10.1211/PJ.2016.20201498.

    Article  Google Scholar 

  85. Shariff Z, Kirby D, Missaghi S, Rajabi-Siahboomi A, Maidment I. Patient-centric medicine design: key characteristics of oral solid dosage forms that improve adherence and acceptance in older people. Pharmaceutics. 2020;12(10) https://doi.org/10.3390/pharmaceutics12100905.

  86. Shariff ZB, Dahmash DT, Kirby DJ, Missaghi S, Rajabi-Siahboomi A, Maidment ID. Does the formulation of Oral solid dosage forms affect acceptance and adherence in older patients? A mixed methods systematic review. J Am Med Dir Assoc. 2020; https://doi.org/10.1016/j.jamda.2020.01.108.

  87. Zhi-Han L, Hui-Yin Y, Makmor-Bakry M. Medication. Handling challenges among visually impaired population. Arch Pharm Pract. 2017;8(1):8–14.

    Article  Google Scholar 

  88. Barbara S, Kritikos V, Anticevich SB. Inhaler technique: does age matter? A systematic review. Eur Respir Rev. 2017; https://doi.org/10.1183/16000617.0055-2017.

  89. Gray SL. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156(9):984. https://doi.org/10.1001/archinte.1996.00440090084008.

    Article  CAS  PubMed  Google Scholar 

  90. Brockmöller J, Stingl JC. Multimorbidity, polypharmacy and pharmacogenomics in old age. Pharmacogenomics. 2017;18(6) https://doi.org/10.2217/pgs-2017-0026.

  91. Curti C, Kirby DJ, Russell CA. Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing. Prog Addit Manuf. 2020;5(2):111–23. https://doi.org/10.1007/s40964-020-00127-5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Aston Pharmacy School, College of Health and Life Sciences, Aston University, Birmingham, UK

    Emma L. Smith & Ian Maidment

Authors
  1. Emma L. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian Maidment
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emma L. Smith .

Editor information

Editors and Affiliations

  1. UCL School of Pharmacy, University College London, London, UK

    Mine Orlu

  2. Department of Clinical Pharmaceutical and Biological Sciences School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK

    Fang Liu

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Smith, E.L., Maidment, I. (2023). Medication Optimisation in Older People. In: Orlu, M., Liu, F. (eds) Pharmaceutical Formulations for Older Patients. AAPS Advances in the Pharmaceutical Sciences Series, vol 51. Springer, Cham. https://doi.org/10.1007/978-3-031-35811-1_1

Download citation

Publish with us

Policies and ethics

Search

Navigation